Kristen McCarthy

Associate
Kristen McCarthy
Boston
+1 617 570 1169

Kristen McCarthy is an associate in the Business Law department and a member of its Life Science group at Goodwin. Kristen represents public and private companies in the pharmaceutical, biotechnology, and medical device industries and advises clients in a variety of corporate matters, including start-up and formation matters, venture capital financings, mergers and acquisitions, initial public offerings, capital markets transactions, strategic investments, and other general corporate matters.

Experience

  • Represented ProMIS Neurosciences its $122.7 million PIPE financing
  • Represented Kymera Therapeutics, Inc. in its $173.7 million initial public offering
  • Represented the underwriters in connection with Freeline Therapeutics Holdings plc’s $158.8 million initial public offering
  • Represented Monte Rosa Therapeutics in its $100 million follow-on offering
  • Represented Cabaletta Bio, Inc. in its $100 million follow-on offering
  • Represented Cabaletta Bio, Inc. in its $35 million follow-on offering
  • Represented scPharmaceuticals, Inc. in its $50 million follow-on offering
  • Represented Cabaletta Bio, Inc. in its $75 million, $100 million and $200 million at-the-market offerings
  • Represented Theseus Pharmaceuticals, Inc. in its $100 million at-the-market offering
  • Represented scPharmaceuticals, Inc. in its $50 million at-the-market offering
  • Represented the underwriters in connection with Evelo Biosciences Inc.’s $72.6 million follow-on offering
  • Represented the underwriters in connection with Precigen, Inc.’s $100 million at-the-market offering
  • Represented the underwriters in connection with Evelo Biosciences Inc.’s $75 million at-the-market offering
  • Represented the underwriters in connection with Ambrx Biopharma Inc.’s $80 million at-the-market offering
  • Represented the underwriters in connection with SQZ Biotechnologies Company’s $60 million at-the-market offering
  • Represented Mercy BioAnalytics, Inc. on its $27 million Series Seed financing and its $41 million Series A financing
  • Represented ARTBIO, Inc. on its $23 million Series Seed financing

Areas of Practice

Professional Experience

While in law school, Kristen served as a law clerk in Goodwin’s REITs practice during the 2018-2019 school year and a summer associate in 2018. She was also the production editor for the Suffolk University Law Review.

Credentials

Education

JD2019

Suffolk University Law School

MS2016

Suffolk University

BS2013

Isenberg School of Management

(minor in Spanish)

Admissions

Bars

  • Massachusetts

Recognition & Awards

Kristen was awarded the Suffolk University Law School’s Jurisprudence award for the highest grade in Criminal Law, Evidence, Contract Law, Secured Transactions and Environmental Law.

Publications

A Deferential Crisis: The Board of Immigration’s Chevron Struggle Concerning Refugee Principles, 52 Suffolk U.L. Rev. 273 (2019).